NO813649L - C-3 sammenknyttede 1-4 dihydropyridiner, deres anvendelse i legemidler og fremgangsmaate til deres fremstilling - Google Patents

C-3 sammenknyttede 1-4 dihydropyridiner, deres anvendelse i legemidler og fremgangsmaate til deres fremstilling

Info

Publication number
NO813649L
NO813649L NO813649A NO813649A NO813649L NO 813649 L NO813649 L NO 813649L NO 813649 A NO813649 A NO 813649A NO 813649 A NO813649 A NO 813649A NO 813649 L NO813649 L NO 813649L
Authority
NO
Norway
Prior art keywords
alkyl
carbon atoms
different
phenyl
residue
Prior art date
Application number
NO813649A
Other languages
English (en)
Norwegian (no)
Inventor
Siegfried Goldmann
Andreas Knorr
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO813649L publication Critical patent/NO813649L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO813649A 1980-11-13 1981-10-28 C-3 sammenknyttede 1-4 dihydropyridiner, deres anvendelse i legemidler og fremgangsmaate til deres fremstilling NO813649L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803042769 DE3042769A1 (de) 1980-11-13 1980-11-13 C-3 verknuepfte 1,4-dihydropyridine, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
NO813649L true NO813649L (no) 1982-05-14

Family

ID=6116648

Family Applications (1)

Application Number Title Priority Date Filing Date
NO813649A NO813649L (no) 1980-11-13 1981-10-28 C-3 sammenknyttede 1-4 dihydropyridiner, deres anvendelse i legemidler og fremgangsmaate til deres fremstilling

Country Status (16)

Country Link
EP (1) EP0052300B1 (fr)
JP (1) JPS57109766A (fr)
AT (1) ATE11773T1 (fr)
AU (1) AU546605B2 (fr)
CA (1) CA1179342A (fr)
DD (1) DD201900A5 (fr)
DE (2) DE3042769A1 (fr)
DK (1) DK501881A (fr)
ES (3) ES507080A0 (fr)
FI (1) FI813567A7 (fr)
GR (1) GR76338B (fr)
HU (1) HU186438B (fr)
IL (1) IL64253A (fr)
NO (1) NO813649L (fr)
PT (1) PT73920B (fr)
ZA (1) ZA817840B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
ATE50987T1 (de) * 1982-05-10 1990-03-15 Takeda Chemical Industries Ltd Dihydropyridinderivate, deren herstellung und verwendung.
US4656181A (en) * 1982-11-24 1987-04-07 Cermol S.A. Esters of 1,4-dihydropyridines, processes for the preparation of the new esters, and medicaments containing the same
EP0145956A1 (fr) * 1983-11-16 1985-06-26 Ciba-Geigy Ag Amide compounds
JPS60120861A (ja) * 1983-12-02 1985-06-28 Otsuka Pharmaceut Co Ltd ジヒドロピリジン誘導体
US4672068A (en) * 1984-05-04 1987-06-09 Fujirebio Kabushiki Kaisha Antihypertensive 1,4-dihydropyridines having a conjugated ester
US4757071A (en) * 1984-12-14 1988-07-12 Nisshin Flour Milling Co., Ltd. 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases
IT1203900B (it) * 1987-04-15 1989-02-23 Lagor Spa Poli 1,4-diidro-2,6-dimetilpiridine 3,5-dicarbossilesteri utili come stabilizzanti termici per polimeri sintetici
GB9002337D0 (en) * 1990-02-02 1990-04-04 Orion Yhtymae Oy Compounds useful in treating inflammatory bowel disease
US5185370A (en) * 1988-09-01 1993-02-09 Orion-Yhtyma Oy Substituted β-diketones and their use
IL91382A (en) * 1988-09-01 1995-06-29 Orion Yhtymae Oy Alkenyl or arylmethylene-substituted beta-diketones their preparation and pharmaceutical compositions containing them
JP2002517440A (ja) * 1998-06-08 2002-06-18 アドバンスド メディスン インコーポレーテッド 新規カルシウムチャンネル薬物および用途
US6897305B2 (en) 1998-06-08 2005-05-24 Theravance, Inc. Calcium channel drugs and uses
US7101909B2 (en) 1998-10-12 2006-09-05 Theravance, Inc. Calcium channel drugs and uses
GB0225548D0 (en) 2002-11-01 2002-12-11 Glaxo Group Ltd Compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795790A1 (de) * 1966-11-16 1975-06-19 Astra Ab Pyridinderivate, verfahren zu deren herstellung und sie enthaltende arzneimittel
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2847236A1 (de) * 1978-10-31 1980-05-14 Bayer Ag Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Also Published As

Publication number Publication date
FI813567L (fi) 1982-05-14
ES510254A0 (es) 1983-02-01
AU7711081A (en) 1982-05-20
DE3168955D1 (en) 1985-03-28
ES8206477A1 (es) 1982-08-16
ES510253A0 (es) 1983-02-01
FI813567A7 (fi) 1982-05-14
AU546605B2 (en) 1985-09-12
EP0052300B1 (fr) 1985-02-13
PT73920A (en) 1981-12-01
ES8303337A1 (es) 1983-02-01
IL64253A0 (en) 1982-02-28
ZA817840B (en) 1982-10-27
DE3042769A1 (de) 1982-06-09
CA1179342A (fr) 1984-12-11
DD201900A5 (de) 1983-08-17
IL64253A (en) 1985-03-31
EP0052300A1 (fr) 1982-05-26
ATE11773T1 (de) 1985-02-15
ES507080A0 (es) 1982-08-16
DK501881A (da) 1982-05-14
ES8303336A1 (es) 1983-02-01
HU186438B (en) 1985-07-29
GR76338B (fr) 1984-08-04
PT73920B (en) 1983-03-29
JPS57109766A (en) 1982-07-08

Similar Documents

Publication Publication Date Title
EP0071819B2 (fr) Dihydropyridines, douées d'une activité inotrope positive, leur application comme médicaments, et leurs procédés de préparation
US4492703A (en) 4-(2-Substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid esters active on blood circulation
EP0176956B1 (fr) Composés diaryliques
EP0094159B1 (fr) Dérivés de la dihydropyridine, leur préparation et leur application
JPH07600B2 (ja) 新規な光学的活性の１，４−ジヒドロピリジン化合物の製造法
CA1086735A (fr) Piperidino-quinazolines
EP0052300A1 (fr) Dihydro-1,4 pyridines reliées entre elles en position 3, leur utilisation dans des médicaments et leurs procédés de préparation
EP0343193A1 (fr) Enantiomeres de 1,4-dihydropyridine
GB2140015A (en) Derivatives of dihydropyridine and production thereof
EP0001769A1 (fr) Esters contenant du soufre d'acides dihydro-1,4-pyridine carboxyliques, leur préparation et leur application comme médicaments
US4565824A (en) Certain nitratoalkyl ester dihydropyridines having antihypertensive properties
US4753936A (en) Circulation-active substituted 1,4-dihydropyridine-3-carboxylic acid piperazides
DK163733B (da) Chromon- og thiochromonsubstituerede 1,4-dihydropyridinderivater, laegemidler indeholdende disse derivater og laegemidlernes fremstilling
NO811424L (no) 1,4-dihydropyridiner med forskjellige substiruenter i 2- og 6-stilling, fremgangsmaate til deres fremstilling og deres anvendelse i legemidler
CA1255660A (fr) Tetrahydrothienopyridines, procede de preparation et utilisation comme medicament
EP0242829A1 (fr) Dihydropyridines, leur procédé de préparation et leur application comme médicaments
DD235867A5 (de) Verfahren zur herstellung von 1,4-dihydropyridinen
DE3779813T2 (de) 1,4-dihydropyridinderivate.
EP0280239B1 (fr) Dérivés de 1,4-dihydropyridine, leur procédé de préparation et leur emploi
US4791122A (en) Circulation active novel 5-aryldihydropyridines
US4798840A (en) Coronary-active fluorine-containing 1,4-dihydropyridines
EP0244595A2 (fr) Dérivés de dihydropyridine, leur procédé de préparation et leur application comme médicaments
EP0220917B1 (fr) Dérivés pharmaceutiques de la dihydro-1,4 pyridine, leurs sels et leur préparation
JP2664941B2 (ja) １，４―ジヒドロピリジン化合物
EP0212107A1 (fr) Esters d'acides dihydro-1,4 sulfamoyl-5 nicotiniques